Skip to main content

Adrian Felipe Hernandez

Duke Health Cardiology Professor
Medicine, Cardiology
Duke Box 3850, Durham, NC 27710
P.O. Box 17969, Durham, NC 27715

Selected Grants


Increasing the Quality and Efficiency of Clinical Trials (U18)

ResearchInvestigator · Awarded by Food and Drug Administration · 2014 - 2029

Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

NIH Health Care Systems Research Collaboratory-Coordinating Center (U24 Clinical Trial Not Allowed)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2028

PREVENTABLE

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2027

Integrated Biostatistical Training for CVD Research

Inst. Training Prgm or CMEMentor · Awarded by North Carolina State University · 2022 - 2027

Increasing the Quality and Efficiency of Clinical Trials (U18)

ResearchInvestigator · Awarded by Food and Drug Administration · 2014 - 2029

Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

NIH Health Care Systems Research Collaboratory-Coordinating Center (U24 Clinical Trial Not Allowed)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2028

PREVENTABLE

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2027

Integrated Biostatistical Training for CVD Research

Inst. Training Prgm or CMEMentor · Awarded by North Carolina State University · 2022 - 2027

ARTEMIS

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2023 - 2027

HERO Program, HERO Registry, HERO-HCQ Trial

Clinical TrialPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2020 - 2025

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Bayer AG · 2023 - 2025

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme LLC. · 2023 - 2025

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2021 - 2025

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Boehringer Ingelheim Pharma GmbH & Co KG · 2022 - 2025

DCRI Think Tanks

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2024 - 2025

HFN NEAT Echo Image Deidentification for the HeartShare Program

ResearchPrincipal Investigator · Awarded by Research Triangle Institute International · 2024 - 2025

DCRI Think Tanks- Alnylam

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Alnylam Pharmaceuticals · 2024 - 2025

DCRI Think Tanks- Intellia Therapeutics Inc

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Intellia Therapeutics, Inc. · 2024 - 2025

Role of the Splanchnic Vascular Compartment in Heart Failure with Preserved Ejection Fraction

ResearchMentor · Awarded by Doris Duke Charitable Foundation, Inc. · 2022 - 2025

EMPA MI Jardiance®, empagliflozin

Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2020 - 2025

Postdoctoral Training in Cardiovascular Clinical Research

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2025

RECOVER Infrastructure Modification 11 (Yr 3)

ResearchCo Investigator · Awarded by Research Triangle Institute International · 2022 - 2025

Mechanisms and Clinical Impact of Myocardial Injury Following Traumatic Brain Injury

ResearchMentor · Awarded by National Institutes of Health · 2019 - 2025

Precision Health Alliance Membership

ResearchPrincipal Investigator · Awarded by Verve Therapeutics, Inc. · 2024 - 2025

Precision Health Alliance Membership

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Beam Therapeutics Inc. · 2024 - 2025

Use and Effectiveness of Outpatient Intravenous Diuretic Therapy as Treatment for Worsening Heart Failure

ResearchMentor · Awarded by American Heart Association · 2022 - 2025

Precision Health Alliance Membership

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by CRISPR Therapeutics · 2024 - 2025

DCRI Think Tanks- Bayer

Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Bayer AG · 2024 - 2025

PCORnet CC - Scope 6 - Playbook

ResearchCo Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2024 - 2025

PRECISION HEALTH GENE EDITING ALLIANCE WORKING GROUP

ResearchPrincipal Investigator · Awarded by Intellia Therapeutics, Inc. · 2023 - 2024

PCORnet CC - SCOPE 4: Strategic Communications to Support the PCORnet Research Community

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2022 - 2024

PCORnet CC - SCOPE 2: Common Data Model Maintenance, Expansion and Linkage

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2022 - 2024

PCORnet CC - SCOPE 1: Program Management, Collaboration and Coordination

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2022 - 2024

ARAMIS Registry (Daiichi Sankyo, Inc.)

ResearchPrincipal Investigator · Awarded by Daiichi Sankyo Inc · 2014 - 2024

PCORnet CC - SCOPE 5: Strategic Communications to Support the PCORnet Research Community

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2023 - 2024

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2023 - 2024

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2021 - 2024

Sherry Lloyd CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Bayer Inc. · 2021 - 2024

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2023 - 2024

Impact of a food purchasing intervention on consumption patterns and improved dietary outcomes in New Orleans

ResearchPrincipal Investigator · Awarded by American Heart Association · 2023 - 2024

Duke CTSA (TL1) Year 5

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024

DCRI Think Tanks- Novo Nordisk, Inc.

ResearchPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2024 - 2024

Collaboratory Resource Coordinating Center for Pragmatic and Implementation Studies for the Management of Pain (PRISM) (U24)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2024

Vericiguat VICTORIA

ResearchPrincipal Investigator · Awarded by Merck · 2016 - 2024

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Intellia Therapeutics, Inc. · 2023 - 2024

FY23 Think Tank AB

ConferencePrincipal Investigator · Awarded by Biogen MA, Inc. · 2022 - 2023

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by SomaLogic · 2022 - 2023

CardioHealth Alliance Membership

Clinical TrialPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2022 - 2023

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Amgen, Inc. · 2022 - 2023

The Project Baseline Community Study (#101143)

ResearchPrincipal Investigator · Awarded by Verily Life Sciences, LLC · 2019 - 2023

ADAPTABLE Supplement

Clinical TrialPD/PI · Awarded by Patient-Centered Outcomes Research Institute · 2015 - 2023

Multidisciplinary Heart and Vascular Diseases

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2023

PRECISION HEALTH GENE EDITING THINK TANK

ResearchPrincipal Investigator · Awarded by Intellia Therapeutics, Inc. · 2023 - 2023

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Pfizer, Inc. · 2022 - 2023

Is Heart Failure with Preserved Edection Fraction the Symptomatic Manifestation of Liver Disease

ResearchCollaborator · Awarded by American Heart Association · 2021 - 2022

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Sanofi US · 2021 - 2022

Dyanavel Safety Study

Clinical TrialPrincipal Investigator · Awarded by Tris Pharma, Inc. · 2019 - 2022

Using the NIH Collaboratory Distributed Research Network to Identify and Characterize ADRD patients

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022

NIH Health Care Systems Research Collaboratory - Coordinating Center

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Eli Lilly and Company · 2021 - 2022

Congestion Phenotypes and Splanchnic Nerve Modulation in Chronic Heart Failure

Clinical TrialMentor · Awarded by National Institutes of Health · 2020 - 2022

Dyanavel Efficacy Study

Clinical TrialPrincipal Investigator · Awarded by Tris Pharma, Inc. · 2019 - 2022

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2021 - 2022

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Bayer HealthCare AG · 2021 - 2022

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Cytokinetics, Inc. · 2021 - 2022

RSV Infant and Older Adults Program Learning Lab

ResearchPrincipal Investigator · Awarded by GlaxoSmithKline Biologicals SA · 2021 - 2022

CV Precision Medicine Research Alliance - Governance

Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2020 - 2021

PCORnet Phase II TO#17- DCRI Leadership

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2020 - 2021

DCRI Think Tank

ConferencePrincipal Investigator · Awarded by Verana Health · 2020 - 2021

Heart Failure Network: Year 12 Non-Compete Renewal

Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2006 - 2021

Baseline Research Consortium

Clinical TrialPrincipal Investigator · Awarded by Verily Life Sciences, LLC · 2019 - 2021

UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021

HFN LIFE Industry Supplemental Funding

Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2020 - 2021

Janssen HERO Vaccine Trial Start Up Budget

Clinical TrialPrincipal Investigator · Awarded by Janssen Pharmaceutica, Inc. · 2020 - 2020

Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)

Clinical TrialCo-Principal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2015 - 2020

Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2013 - 2020

Task Order 1: CC Phase II Master Contract Leadership

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2016 - 2020

PCORnet Phase II TO#15

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2019 - 2020

TO#4 CC Leadership

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2016 - 2020

Splanchnic Nerve Block for Therapy of Acute Heart Failure (Splanchnic HF)

Clinical TrialCo-Mentor · Awarded by American Heart Association · 2017 - 2019

PCORnet Phase II Rapid Research TO#13 Mod 2

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2016 - 2019

HFN / HIV Supplement

Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2019

Methodology for Linking Clinical and Administrative Databases

ResearchCo Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2014 - 2019

Health Care Systems Research Collaboratory - Coordinating Center

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2019

Thrombolysis in Ischemic Stroke Patients: Recent Stroke,AM Infarction,Major Surgery, Combo Prev Stroke Diabetes Mellitus

ResearchCollaborating Investigator · Awarded by American Heart Association · 2014 - 2019

Task Order 7: Front Door

Clinical TrialPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2016 - 2019

PCORNet Communications - Engagement Materials

ResearchPrincipal Investigator · Awarded by Genetic Alliance · 2016 - 2018

A Collaboration for Improving Outcomes of African Americans with Heart Failure

ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2018

CardioMEMS

Clinical TrialMentor · Awarded by Pacesetter, Inc. · 2016 - 2018

PCORnet TO#7 Planning Project with Genetic Alliance

ResearchPrincipal Investigator · Awarded by Genetic Alliance · 2016 - 2017

GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (DCC)

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2012 - 2017

Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2013 - 2016

PCORI Short Term Communications Procurement Plan

ResearchPrincipal Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2016 - 2016

Validating and Extending the PROMIS Sexual Function Measure for Clinical Research

ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2015

Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF

ResearchCo Investigator · Awarded by National Institutes of Health · 2010 - 2014

ICD Therapy in Patients with Congestive Heart Failure

ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2014

Improving Methods for Comparative Effectiveness Research in Cardiovascular Care

ResearchCollaborator · Awarded by Agency for Healthcare Research and Quality · 2008 - 2013

DECIDE 2

ResearchDeputy Director · Awarded by Agency for Healthcare Research and Quality · 2010 - 2013

Comparative Effectiveness of Therapies for Heart Failure

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2010 - 2013

TO # 1 - Coordinating Center for Cardiovascular Disease - OPTION YEAR 2

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2011 - 2013

A Randomized, Controlled Pilot Study of an Intervention for Medication Adherence

ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2012

Duke Cardiovascular CERTs

ResearchCo Investigator · Awarded by Agency for Healthcare Research and Quality · 2007 - 2012

Heart Failure Clinical Research Network - DCC

ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2011

TO # 1 - Coordinating Center for Cardiovascular Disease

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2010 - 2011

Stakeholder Support and Meetings for the DEcIDE Cardiovascular Consortium

ResearchPrincipal Investigator · Awarded by Agency for Healthcare Research and Quality · 2009 - 2010

DCRI Research Center for CERTs

ResearchCo Investigator · Awarded by Agency for Healthcare Research and Quality · 1999 - 2008

External Relationships


  • Boehringer Ingleheim
  • Boston Scientific Corporation
  • Bristol Myers Squibb
  • Cytokinetics, Inc.
  • Eidos Therapeutics
  • Boehringer Ingleheim
  • Boston Scientific Corporation
  • Bristol Myers Squibb
  • Cytokinetics, Inc.
  • Eidos Therapeutics
  • GlaxoSmithKline
  • Intellia
  • Intercept
  • MyoKardia
  • Novartis
  • Novo Nordisk
  • Prolaio
  • TikkunLev Therapeutics, Inc

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.